Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.

Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, Larsson A, Landegren UD, Kamali-Moghaddam M.

Proc Natl Acad Sci U S A. 2011 May 24;108(21):8809-14. doi: 10.1073/pnas.1019330108. Epub 2011 May 9.

2.

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.

Lance RS, Drake RR, Troyer DA.

Expert Rev Anticancer Ther. 2011 Sep;11(9):1341-3. doi: 10.1586/era.11.134.

PMID:
21929308
3.

Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men.

Clements JA, Merritt T, Devoss K, Swanson C, Hamlyn L, Scells B, Rohde P, Lavin MF, Yaxley J, Gardiner RA.

BJU Int. 2000 Sep;86(4):453-8.

4.

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9.

5.

Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.

Finlay JA, Evans CL, Day JR, Payne JK, Mikolajczyk SD, Millar LS, Kuus-Reichel K, Wolfert RL, Rittenhouse HG.

Urology. 1998 May;51(5):804-9.

PMID:
9610595
6.

Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.

Stamey TA, Graves HC, Wehner N, Ferrari M, Freiha FS.

J Urol. 1993 Apr;149(4):787-92.

PMID:
7681119
7.

Prothrombotic effects of prostasomes isolated from prostatic cancer cell lines and seminal plasma.

Babiker AA, Ekdahl KN, Nilsson B, Ronquist G.

Semin Thromb Hemost. 2007 Feb;33(1):80-6. Review.

PMID:
17253194
8.

Prothrombotic effect of prostasomes of metastatic cell and seminal origin.

Babiker AA, Hamad OA, Sanchez J, Ronquist G, Nilsson B, Ekdahl KN.

Prostate. 2007 Mar 1;67(4):378-88.

PMID:
17219380
9.

A sensitive proximity ligation assay for active PSA.

Zhu L, Koistinen H, Wu P, Närvänen A, Schallmeiner E, Fredriksson S, Landegren U, Stenman UH.

Biol Chem. 2006 Jun;387(6):769-72.

PMID:
16800738
10.

Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.

Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM.

Cancer Res. 2000 Dec 15;60(24):7142-8.

11.

Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.

Block AS, Saraswati S, Lichti CF, Mahadevan M, Diekman AB.

Prostate. 2011 May 15;71(7):711-21. doi: 10.1002/pros.21287. Epub 2010 Oct 28.

12.

Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.

Schambeck CM, Schmeller N, Stieber P, Jansen HM, Pahl H, Schneider W, Fateh-Moghadam A.

Urology. 1995 Aug;46(2):195-9.

PMID:
7542821
13.

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.

Horninger W, Cheli CD, Babaian RJ, Fritsche HA, Lepor H, Taneja SS, Childs S, Stamey TA, Sokoll LJ, Chan DW, Brawer MK, Partin AW, Bartsch G.

Urology. 2002 Oct;60(4 Suppl 1):31-5.

PMID:
12384160
14.

Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.

Zehentner BK, Secrist H, Zhang X, Hayes DC, Ostenson R, Goodman G, Xu J, Kiviat M, Kiviat N, Persing DH, Houghton RL.

Mol Diagn Ther. 2006;10(6):397-403.

PMID:
17154657
15.

[Clinical value of prostate specific antigen screening in early detection of prostate cancer].

Hua LX, Qiao D, Song NH, Feng NH, Yang J, Zhang JX, Chen JG, Zhang W, Sui YG, Wu HF.

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):705-9. Chinese.

PMID:
20021870
16.

Antiprostasome antibody titres in benign and malignant prostate disease.

Minelli A, Ronquist G, Carlsson L, Mearini E, Nilsson O, Larsson A.

Anticancer Res. 2005 Nov-Dec;25(6C):4399-402.

19.

Antiprostasome antibodies: possible serum markers for prostate cancer metastasizing liability.

Larsson A, Ronquist G, Wülfing C, Eltze E, Bettendorf O, Carlsson L, Nilsson BO, Semjonow A.

Urol Oncol. 2006 May-Jun;24(3):195-200.

PMID:
16678048
20.

Prostate cancer screening in the Tyrol, Austria: experience and results.

Horninger W, Reissigl A, Rogatsch H, Volgger H, Studen M, Klocker H, Bartsch G.

Eur J Cancer. 2000 Jun;36(10):1322-35. Retraction in: Eur J Cancer. 2012 Jan;48(2):286.

PMID:
10882875
Items per page

Supplemental Content

Write to the Help Desk